| NCT00515463 | Amgen | Low Bone Mineral Density|Osteopenia|Osteoporosis | 2007-05 | PHASE3 |
| NCT02129699 | ETOP IBCSG Partners Foundation|European Organisation for Research and Treatment of Cancer - EORTC|Amgen | Lung Cancer Non-small Cell Stage IV | 2015-01-06 | PHASE3 |
| NCT04169698 | Ain Shams University|Nahda University | Osteoporosis, Osteopenia|Renal Transplant Recipient | 2019-10-17 | PHASE2|PHASE3 |
| NCT00980174 | Amgen | Low Bone Mass|Low Bone Mineral Density|Males With Osteoporosis|Osteopenia|Osteoporosis | 2009-10-01 | PHASE3 |
| NCT05106517 | Shenzhen People´s Hospital | Denosumab vs Zoledronate | 2021-09-08 | PHASE2|PHASE3 |
| NCT01419717 | Amgen | Bone Metastases in Men With Hormone-Refractory Prostate Cancer|Bone Metastases in Subjects With Advanced Breast Cancer | 2011-11-22 | PHASE3 |
| NCT03960554 | Thomas Nickolas, MD MS | Osteoporosis|Renal Osteodystrophy|Kidney Transplant; Complications | 2020-01-16 | PHASE2 |
| NCT07537972 | Tongji Hospital | Hepatocellular Carcinoma (HCC)|Bone Metastases | 2026-05-01 | PHASE2 |
| NCT03259152 | Hebei Medical University Third Hospital | Giant Cell Tumor of Bone | 2016-05-01 | PHASE3 |
| NCT02721433 | Ottawa Hospital Research Institute | Breast Cancer|Prostate Cancer|Metastasis | 2016-08 | PHASE4 |
| NCT04467983 | Hospital for Special Surgery, New York|Radius Health, Inc.|Crozer-Keystone Health System | Osteoporosis, Postmenopausal | 2021-02-01 | PHASE4 |
| NCT00330759 | Amgen | Bone Metastases | 2006-06-01 | PHASE3 |
| NCT02613416 | Alison Stopeck|Amgen | Breast Cancer | 2015-11 | PHASE2 |
| NCT00259740 | Amgen | Relapsed or Plateau-Phase Multiple Myeloma | 2005-11 | PHASE2 |
| NCT03921060 | University of Texas Southwestern Medical Center | Cystic Fibrosis | 2021-09-02 | PHASE4 |
| NCT05278338 | Shanghai JMT-Bio Inc. | Postmenopausal Osteoporosis | 2022-04-21 | PHASE2 |
| NCT03822078 | Amgen | Osteoporosis | 2003-09-30 | PHASE1 |
| NCT01750086 | Massachusetts General Hospital | Postmenopausal Osteoporosis | 2013-01 | PHASE4 |
| NCT05203588 | Shanghai Changzheng Hospital | Osteoporosis|Fusion of Spine, Lumbar Region | 2021-10-09 | PHASE4 |
| NCT00321620 | Amgen | Bone Metastases | 2006-04-01 | PHASE3 |
| NCT05091086 | National Taiwan University Hospital | Osteoporosis|Bone Mineral Density | 2021-11-20 | PHASE4 |
| NCT01864798 | Jules Bordet Institute|Melbourne Health | Breast Neoplasms | 2013-07 | PHASE2 |
| NCT05559268 | The Affiliated Hospital of Qingdao University | Osteoarthritis, Knee | 2022-10-01 | PHASE4 |
| NCT07283887 | National Taiwan University Hospital | Osteoporosis | 2025-12-03 | PHASE4 |
| NCT07034391 | China Medical University, China | Non-Small Cell Lung Cancer | 2025-05-12 | PHASE2 |
| NCT01077154 | Amgen|Daiichi Sankyo | Breast Cancer | 2010-06-02 | PHASE3 |
| NCT05736640 | University of Aarhus | Osseointegrated Implants|Bone Mineral Density | 2013-09-01 | NA |
| NCT05010590 | Massachusetts General Hospital | Postmenopausal Osteoporosis | 2022-03-24 | PHASE4 |
| NCT01457950 | GlaxoSmithKline | Osteoporosis, Postmenopausal | 2011-11 | PHASE3 |
| NCT01624766 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Advanced Malignant Neoplasm|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm|Refractory Malignant Neoplasm | 2012-06-19 | PHASE1 |
| NCT03415477 | Peking University People´s Hospital | Bone Cyst Aneurysmal|Pathological Fracture|Recurrent Disease|Refractory Tumor | 2014-01-01 | PHASE1|PHASE2 |
| NCT00887965 | Amgen | Low Bone Mass|Low Bone Mineral Density|Osteoporosis|Postmenopausal Osteoporosis | 2009-06 | PHASE2 |
| NCT06706414 | Martin Blomberg Jensen | Infertility, Male | 2025-03-01 | PHASE1|PHASE2 |
| NCT00523341 | Amgen | Osteopenia|Osteoporosis | 2007-08-07 | PHASE3 |
| NCT05866029 | Peking Union Medical College Hospital | Osteoporotic Fractures | 2023-05-26 | NA |
| NCT05493761 | Aristotle University Of Thessaloniki|424 General Military Hospital | Nonalcoholic Fatty Liver|Osteoporosis, Postmenopausal | 2022-12-23 | PHASE4 |
| NCT06164795 | 424 General Military Hospital | Osteoporosis, Postmenopausal | 2023-11-25 | |
| NCT04232657 | VA Office of Research and Development|Kessler Institute for Rehabilitation | Spinal Cord Injury (=3 Years)|Sublesional Bone Loss Secondary to SCI | 2021-03-01 | PHASE2 |
| NCT00330460 | Amgen | Osteoporosis|Osteopenia | 2006-05 | PHASE3 |
| NCT02422108 | Martin Blomberg Jensen | Testis|Infertility|Sperm | 2015-05 | PHASE2 |
| NCT00043186 | Amgen | Low Bone Mineral Density | 2002-05 | PHASE2 |
| NCT04907539 | Redx Pharma Ltd | Colorectal Cancer | 2021-11-08 | PHASE2 |
| NCT00925600 | Amgen | Cancer|Cataract|Low Bone Mineral Density|Osteopenia|Osteoporosis|Prostate Cancer | 2009-11-30 | PHASE3 |
| NCT04026256 | Massachusetts General Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Postmenopausal Osteoporosis | 2019-09-02 | PHASE4 |
| NCT02903446 | University of Alabama at Birmingham|University of Auckland, New Zealand | Gout | 2017-02-01 | PHASE2 |
| NCT00680953 | Daiichi Sankyo Co., Ltd. | Osteoporosis | 2008-05 | PHASE3 |
| NCT06095427 | Luye Pharma Group Ltd.|Parexel | Healthy | 2021-03-09 | PHASE1 |
| NCT02049866 | Elizabeth Shane|Creighton University | Adult Idiopathic Generalized Osteoporosis | 2014-11-19 | PHASE2 |
| NCT01732770 | Amgen | Post Menopausal Osteoporosis | 2012-11-07 | PHASE4 |
| NCT02014467 | GlaxoSmithKline | Osteoporosis, Postmenopausal | 2014-01 | PHASE3 |
| NCT02444585 | University of Southern California|Orthopaedic Institute for Children | Arthroplasty, Replacement, Hip | 2017-02-28 | PHASE1 |
| NCT03382574 | National Cancer Institute (NCI) | Ovarian Carcinoma | 2019-03-14 | EARLY_PHASE1 |
| NCT00377819 | Amgen | Postmenopausal Osteoporosis | 2006-09 | PHASE3 |
| NCT05598606 | Shenzhen People´s Hospital | Denosumab Allergy|Zoledronic Acid Allergy | 2021-01-12 | PHASE4 |
| NCT02157948 | Amgen | Postmenopausal Osteoporosis | 2014-05 | PHASE3 |
| NCT03620149 | European Organisation for Research and Treatment of Cancer - EORTC|Amgen | Bone Giant Cell Tumor | 2019-09-26 | PHASE2 |
| NCT07271771 | Aarhus University Hospital|Sponsor: MD, Professor, DMSc, PhD Bente Lomholt Langdahl | Osteoporosis | 2024-05-21 | PHASE4 |
| NCT03532087 | Borstkanker Onderzoek Groep|Amgen | Breast Neoplasms | 2018-02 | PHASE2 |
| NCT03280667 | Australian and New Zealand Urogenital and Prostate Cancer Trials Group|Merck Sharp & Dohme LLC|Amgen | Renal Cell Carcinoma, Clear Cell|Metastatic Kidney Cancer | 2017-12-12 | PHASE2 |
| NCT05419050 | National Institute of Dental and Craniofacial Research (NIDCR) | Fibrous Dysplasia | 2022-10-12 | PHASE2 |
| NCT00838201 | Amgen | Cancer|Carcinoma|Castrate-Resistant Prostate Cancer|Prostate Cancer|Tumors | 2009-02-01 | PHASE3 |
| NCT02366130 | M.D. Anderson Cancer Center|Bayer | Breast Cancer | 2015-02-11 | PHASE2 |
| NCT03027557 | Peter Vestergaard|Aalborg University | Primary Hyperparathyroidism|Parathyroid Adenoma|Parathyroid Hyperplasia | 2017-03-01 | PHASE3 |
| NCT00680992 | Amgen | Cancer|Giant Cell Tumors|Giant Cell Tumor of Bone|Benign Giant Cell Tumors | 2008-09-09 | PHASE2 |
| NCT03605199 | Leiden University Medical Center|Amgen | Aneurysmal Bone Cysts|Giant Cell Granuloma|Osteoblastoma|Chondroblastoma|Chondromyxoid Fibroma | 2018-06-18 | PHASE2 |
| NCT04608630 | Australian and New Zealand Intensive Care Research Centre | Critical Illness|Osteoporosis | 2021-07-15 | PHASE2 |
| NCT03638128 | Amgen | Osteogenesis Imperfecta (OI) | 2018-07-26 | PHASE3 |
| NCT03070002 | Northwestern University|Amgen|National Cancer Institute (NCI) | Breast Carcinoma Metastatic in the Bone|Circulating Tumor Cell Count|Estrogen Receptor Positive|HER2+Neu Negative|Progesterone Receptor Positive|Stage IV Breast Cancer | 2017-10-19 | PHASE2 |
| NCT01753856 | Eli Lilly and Company | Osteoporosis | 2013-01 | PHASE4 |
| NCT05876949 | Alvotech Swiss AG | This is a Phase I Study Conducted in Healthy Volunteers | 2023-07-21 | PHASE1 |
| NCT05395091 | Alvotech Swiss AG | Osteoporosis, Postmenopausal | 2022-08-23 | PHASE3 |
| NCT06720350 | Marmara University | Osteoporosis in Post-menopausal Women | 2025-01-15 | PHASE4 |
| NCT03292146 | Massachusetts General Hospital|Amgen | Bone Density|Bone Loss|Anorexia Nervosa|Eating Disorder|Atypical Anorexia Nervosa | 2017-10-25 | PHASE3 |
| NCT04621318 | Samsung Bioepis Co., Ltd. | Healthy | 2020-10-19 | PHASE1 |
| NCT03239080 | Chinese University of Hong Kong | Rheumatoid Arthritis | 2017-06-19 | PHASE2 |
| NCT06272227 | Yonsei University | Sarcopenia | 2024-02-13 | PHASE4 |
| NCT04087096 | Massachusetts General Hospital|University of California, San Francisco|San Francisco VA Health Care System | Bariatric Surgery Candidate|Bone Loss | 2020-08-24 | PHASE4 |
| NCT00518531 | Amgen | Osteoporosis | 2007-09-01 | PHASE3 |
| NCT06472050 | Tuen Mun Hospital | Osteoporosis|Glucocorticoids Toxicity | 2024-08-20 | PHASE4 |
| NCT04231682 | Albert Einstein Healthcare Network|Amgen | Osteoporosis | 2020-07-01 | PHASE2 |
| NCT01221727 | Amgen | Postmenopausal Osteoporosis | 2010-11 | PHASE1 |
| NCT03005678 | Tuen Mun Hospital | Osteoporosis | 2017-04-01 | PHASE4 |
| NCT04547348 | Ole Lander Svendsen | Charcot Foot|Diabetes Mellitus | 2020-11-01 | PHASE3 |
| NCT03408652 | Centre Leon Berard | Metastatic Renal Cell Carcinoma | 2019-03-15 | PHASE3 |
| NCT04702204 | Nigde Omer Halisdemir University | Postmenopausal Osteoporosis | 2020-07-01 | |
| NCT03324932 | Kyoto Prefectural University of Medicine | Breast Cancer | 2017-09-25 | PHASE3 |
| NCT02567279 | University Hospital, Montpellier|University Hospital, Lille|Nantes University Hospital|University Hospital, Paris|University Hospital, Rouen | Anorexia Nervosa | 2016-06-01 | PHASE3 |
| NCT00095498 | Amgen | Rheumatoid Arthritis | 2004-08-11 | PHASE2 |
| NCT05966064 | Natasha Appelman-Dijkstra | Fibrous Dysplasia|McCune Albright Syndrome | 2023-06-13 | PHASE4 |
| NCT01575834 | Amgen | Postmenopausal Osteoporosis | 2012-03-15 | PHASE3 |
| NCT00091832 | Amgen | Breast Cancer|Metastases|Bone Metastases in Subjects With Advanced Breast Cancer | 2004-09 | PHASE2 |
| NCT06938152 | National Taiwan University Hospital | Osteoporosis|Osteoporosis Postmenopausal | 2025-04-08 | PHASE4 |
| NCT01920568 | GlaxoSmithKline|Amgen | Fractures, Bone | 2013-08 | PHASE3 |
| NCT01799798 | University of Cologne | Osteogenesis Imperfecta | 2013-02 | PHASE2 |
| NCT01734824 | Medical University of Vienna | Bone Marrow Oedema Syndrome|High Turnover Bone Disease|Quality of Life | 2012-05 | PHASE4 |
| NCT02156960 | Shinshu University | Osteoporosis | 2014-05 | PHASE4 |
| NCT01973569 | Daiichi Sankyo | Rheumatoid Arthritis | 2013-10 | NA |
| NCT02299817 | Olof Skoldenberg|Danderyd Hospital | Osteolysis | 2015-08 | PHASE2 |
| NCT05435768 | Second Affiliated Hospital of Soochow University | Metastatic Solid Tumor | 2022-08-16 | |
| NCT03958565 | University of Colorado, Denver|Cancer League of Colorado | Carcinoma, Non-Small-Cell Lung | 2020-04-28 | |
| NCT03868033 | National Taiwan University Hospital | Osteoporosis | 2019-04-12 | PHASE4 |
| NCT05884372 | Xi´an Honghui Hospital|Chugai Pharma China Co., Ltd. | Osteoporosis in Postmenopausal Women | 2023-08-24 | PHASE4 |
| NCT05638399 | Shenzhen People´s Hospital | Osteopenia|Lumbar Spondylolisthesis | 2020-01-15 | PHASE3 |
| NCT03164928 | Amgen | Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With|Glucocorticoid-induced Osteoporosis | 2018-05-07 | PHASE3 |
| NCT00321464 | Amgen|Daiichi Sankyo | Bone Metastases | 2006-04-01 | PHASE3 |
| NCT05419427 | Lambda Therapeutic Research Ltd.|Intas Pharmaceutical Limited (Biopharma Division) | Osteoporosis, Postmenopausal | 2021-11-11 | PHASE3 |
| NCT06643780 | Prince of Wales Hospital, Shatin, Hong Kong|Chinese University of Hong Kong | Sarcopenia in Elderly | 2024-04-09 | PHASE4 |
| NCT05096195 | Western University, Canada|ICES|Academic Medical Organization of Southwestern Ontario|Western University|The Kidney Foundation of Canada | Kidney Diseases|Dialysis; Complications|Fragility Fracture|Chronic Kidney Disease-Mineral and Bone Disorder | 2022-06-11 | PHASE4 |
| NCT00089661 | Amgen | Breast Cancer|Low Bone Mineral Density|Osteopenia | 2004-10-01 | PHASE3 |
| NCT01377467 | Rudolf Wuethrich | Osteoporosis|Chronic Kidney Disease | 2011-06 | PHASE3 |
| NCT04800367 | Columbia University|Amgen | Premenopausal Idiopathic Osteoporosis | 2021-03-12 | PHASE2 |
| NCT00896454 | Amgen | Breast Cancer|Hypercalcemia of Malignancy|Colon Cancer|Endocrine Cancer|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Metastatic Cancer|Multiple Myeloma|Parathyroid Neoplasms|Renal Cancer|Thyroid Cancer|Hodgkin´s Lymphoma|Non-Hodgkin´s Lymphoma|Non-Small Cell Lung Cancer | 2009-11-16 | PHASE2 |
| NCT07281586 | National Taiwan University Hospital|National Taiwan University Hospital, Yun-Lin Branch | Osteoporosis | 2026-01-01 | PHASE4 |
| NCT01652690 | Amgen|One Amgen Center Drive|THOUSAND OAKS|CA|91320-1799|USA | Osteoporosis, Postmenopausal | 2012-06-26 | |
| NCT07085520 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Osteoarthritis|Osteoarthritis (OA) of the Knee|Osteoporosis|Osteoporosis (Senile)|Healthy | 2025-07-31 | PHASE1 |
| NCT00293813 | Amgen | Postmenopausal Osteoporosis | 2006-05 | PHASE2 |
| NCT06154707 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Sarcopenia|Osteoporosis|Denosumab | 2024-02-01 | PHASE3 |
| NCT05813665 | Shanghai JMT-Bio Inc. | Giant Cell Tumor of Bone | 2023-04 | PHASE3 |
| NCT04711109 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Austrian Breast & Colorectal Cancer Study Group | BRCA1 Mutation|Breast Cancer|Breast Diseases|Breast Neoplasms|Breast Carcinoma|Neoplasms | 2023-02-14 | PHASE3 |
| NCT01345019 | Amgen|Daiichi Sankyo | Cancer|Hematologic Malignancies|Multiple Myeloma|Oncology|Bone Metastases|Multiple Myeloma Bone Lesions | 2012-05-17 | PHASE3 |
| NCT02304887 | Toshihiko Kono | Osteoporosis | 2006-01 | |
| NCT00556374 | Amgen|Austrian Breast & Colorectal Cancer Study Group | Breast Cancer | 2006-12-18 | PHASE3 |
| NCT02682693 | GBG Forschungs GmbH|Amgen|Celgene Corporation | Breast Cancer Female NOS|Tubular Breast Cancer Stage II|Mucinous Breast Cancer Stage II|Invasive Ductal Breast Cancer|HER2 Positive Breast Cancer|Inflammatory Breast Cancer|Tubular Breast Cancer Stage III | 2017-02-13 | PHASE2 |
| NCT05692297 | Capital Medical University | Chronic Kidney Diseases|Fracture|Bone Density, Low|End Stage Renal Disease | 2023-01-01 | NA |
| NCT02559648 | Ersi Voskaridou | Thalassemia Major|Osteoporosis | 2014-09 | PHASE2 |
| NCT03457818 | Mishaela Rubin | Diabetes Mellitus, Type 2|Osteoporosis | 2018-11-07 | PHASE2 |
| NCT03174366 | Western University of Health Sciences | Charcot Joint of Foot | 2017-05-16 | PHASE3 |
| NCT00286091 | Amgen | Hormone Refractory Prostate Cancer | 2006-01-24 | PHASE3 |
| NCT02099461 | Amgen | Healthy Volunteer, Female, Breast | 2014-04 | PHASE1 |
| NCT05402865 | Shanghai JMT-Bio Inc. | Giant Cell Tumor of Bone | 2021-11-10 | |
| NCT03301857 | Amgen | Giant Cell Tumor of Bone | 2017-11-13 | PHASE4 |
| NCT03358212 | Peking University People´s Hospital | Giant Cell Tumor of Bone | 2018-03-01 | |
| NCT01572545 | Aristotle University Of Thessaloniki|424 General Military Hospital|251 Hellenic Air Force & VA General Hospital | Postmenopausal Osteoporosis | 2012-04 | NA |
| NCT05065164 | Shenzhen People´s Hospital | Denosumab Allergy | 2021-09-14 | PHASE2|PHASE3 |
| NCT02101164 | Amgen | Solid Tumor|Metastatic Bone Disease | 2014-11 | PHASE4 |
| NCT00919711 | Amgen | Osteoporosis | 2009-09-01 | PHASE3 |
| NCT06524960 | City of Hope Medical Center | Type 1 Diabetes | 2024-09-03 | PHASE1|PHASE2 |
| NCT03030196 | Martin Blomberg Jensen | Infertility, Male | 2017-01 | PHASE2 |
| NCT06314698 | RenJi Hospital|Shanghai JMT-Bio Inc. | Multiple Myeloma|Bone Diseases | 2024-04-01 | PHASE3 |
| NCT03293108 | AryoGen Pharmed Co. | Osteoporosis | 2017-04-29 | PHASE3 |
| NCT02758132 | University of Hawaii | Prostate Cancer | 2016-03-01 | PHASE2 |
| NCT07063797 | Peking Union Medical College Hospital | Type 2 Diabetes|Osteoporosis|Fractures | 2026-02-01 | NA |
| NCT03629717 | Washington University School of Medicine | Breast Cancer Prevention|Mammographic Density | 2018-06-01 | EARLY_PHASE1 |
| NCT03270020 | Hellenic Society for the Study of Bone Metabolism | Langerhans Cell Histiocytosis | 2017-09-07 | PHASE2 |
| NCT07546552 | Peter Humaidan|Herlev Hospital | Female Infertility|NF-κB Ligand|RANKL|Osteoporosis|Follicle Development | 2025-08-01 | NA |
| NCT03925532 | Roswell Park Cancer Institute|Amgen | Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Osteopenia|Osteoporosis | 2019-12-19 | PHASE2 |
| NCT03401060 | Assistance Publique - H?pitaux de Paris|CEREMAST|URC-CIC Paris Descartes Necker Cochin | Osteoporosis|Systemic Mastocytosis | 2018-03-05 | PHASE3 |
| NCT01869686 | Amgen | Healthy Volunteer | 2013-06 | PHASE1 |
| NCT02554695 | Mayo Clinic | Bone Loss|Aging | 2015-10-20 | EARLY_PHASE1 |
| NCT00936897 | Amgen | Postmenopausal Osteoporosis | 2009-07 | PHASE3 |
| NCT02053753 | Amgen | Healthy Volunteer | 2014-02 | PHASE1 |
| NCT02853539 | Stanley Dudrick´s Memorial Hospital | Metabolic Bone Disease | 2011-01 | PHASE4 |
| NCT01983475 | James J. Peters Veterans Affairs Medical Center|Kessler Institute for Rehabilitation | Osteoporosis|Spinal Cord Injury | 2015-01 | PHASE4 |
| NCT05666310 | Nami Safai Haeri|The Claude D. Pepper Older Americans Independence Centers|National Institute on Aging (NIA) | Sarcopenia|Osteoporosis | 2023-02-14 | PHASE4 |
| NCT02760979 | Fundació Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau | Bone Resorption | 2013-01 | PHASE4 |
| NCT02677246 | St. Justine´s Hospital | Disorder Related to Bone Marrow Transplantation | 2016-12 | PHASE1 |
| NCT00396279 | Amgen | GCT|Giant Cell Tumor of Bone | 2006-07-10 | PHASE2 |
| NCT01978483 | Innovaderm Research Inc. | Ultraviolet Rays|Immunosuppression|Hypersensitivity, Delayed|Immune Tolerance+Drug Effects | 2013-11 | PHASE1 |
| NCT02321280 | University of Manitoba|University of Toronto|McMaster University | Crohn Disease | 2015-02 | PHASE1|PHASE2 |
| NCT02051218 | Swiss Cancer Institute | Metastatic Breast Cancer|Metastatic Prostate Cancer|Bone Metastases | 2014-07-16 | PHASE3 |
| NCT05058443 | Shenzhen People´s Hospital | Osteoporotic Vertebral Compression Fracture | 2020-01-06 | PHASE2|PHASE3 |
| NCT05101018 | James J. Peters Veterans Affairs Medical Center|Kessler Institute for Rehabilitation | Osteoporosis|Spinal Cord Injuries | 2021-11-01 | PHASE4 |
| NCT01545648 | Hope Rugo, MD|University of California, San Francisco|Amgen | Early Stage Breast Cancer | 2012-11-01 | PHASE2 |
| NCT02771860 | University Hospital, Ghent|Amgen | Hand Osteoarthritis | 2016-03 | PHASE2 |
| NCT04034199 | Kwong Wah Hospital|Tung Wah Group of Hospitals | Idiopathic Inflammatory Myopathies|Osteoporosis, Osteopenia | 2019-08-15 | PHASE3 |
| NCT01630941 | Hans Mallmin | Osteoarthritis, Hip|Ambulation Difficulty | 2012-08-07 | PHASE2 |
| NCT02491515 | Tomidahama Hospital | Osteoporosis | 2012-07 | |
| NCT06300229 | Martin Blomberg Jensen | Infertility, Male | 2024-03-01 | PHASE1|PHASE2 |
| NCT03040765 | Hamad Medical Corporation | Thalassemia Majors (Beta-Thalassemia Major)|Osteoporosis | 2018-05-14 | PHASE3 |
| NCT00896532 | Amgen | Low Bone Mineral Density|Postmenopausal Osteoporosis | 2009-06-03 | PHASE2 |
| NCT02499237 | 424 General Military Hospital|251 Hellenic Air Force & VA General Hospital|Leiden University Medical Center | Postmenopausal Osteoporosis | 2015-07 | PHASE4 |
| NCT03620019 | UNC Lineberger Comprehensive Cancer Center|Amgen | Melanoma Stage Iii|Melanoma Stage Iv|Melanoma|Melanoma (Skin)|Cutaneous Melanoma | 2018-09-10 | PHASE2 |
| NCT04664959 | Samsung Bioepis Co., Ltd. | Postmenopausal Osteoporosis | 2020-11-26 | PHASE3 |
| NCT02176382 | Massachusetts General Hospital | Postmenopausal Osteoporosis | 2014-08 | PHASE4 |
| NCT01952054 | M.D. Anderson Cancer Center|Amgen | Breast Cancer | 2015-02-09 | PHASE2 |
| NCT04907851 | Redx Pharma Ltd|Merck Sharp & Dohme LLC | Advanced Solid Tumours | 2021-12-10 | PHASE2 |
| NCT03923842 | Gruppo Oncologico del Nord-Ovest|Mario Negri Institute for Pharmacological Research | Nasopharyngeal Carcinoma|EBV Related Carcinoma | 2019-06-30 | PHASE2 |
| NCT06118905 | Susan L. Greenspan | Osteoporosis | 2024-02-08 | PHASE4 |
| NCT06749886 | Shanghai Pulmonary Hospital, Shanghai, China | Lung Cancer | 2024-11-19 | PHASE2 |
| NCT03520231 | University Health Network, Toronto|Amgen | Urothelial Carcinoma|Kidney Cancer|Ureter Cancer|Bladder Cancer | 2018-09-04 | PHASE2 |
| NCT05853354 | Luye Pharma Group Ltd. | Osteoporosis, Postmenopausal | 2023-04-05 | PHASE3 |
| NCT02520362 | Amgen|Aarhus University Hospital|Optum, Inc.|University of Alabama at Birmingham | Osteoporosis | 2010-05-31 | |
| NCT06357741 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Knee Osteoarthritis | 2021-08-01 | |
| NCT05415657 | Shenzhen People´s Hospital | Osteopenia|Spine Fusion|Denosumab Allergy | 2020-01-12 | NA |
| NCT03029442 | James J. Peters Veterans Affairs Medical Center|Kessler Institute for Rehabilitation | Secondary Osteoporosis|Spinal Cord Injury | 2017-04-01 | PHASE4 |
| NCT03623633 | Massachusetts General Hospital | Osteoporosis, Postmenopausal|Osteoporosis | 2018-11-30 | PHASE4 |
| NCT03571191 | National Institute of Dental and Craniofacial Research (NIDCR) | Bone Diseases|Pain | 2019-06-13 | PHASE2 |
| NCT02470091 | Children´s Oncology Group|National Cancer Institute (NCI) | Metastatic Osteosarcoma|Recurrent Osteosarcoma|Refractory Osteosarcoma|Stage IV Osteosarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7 | 2015-11-21 | PHASE2 |
| NCT00926380 | Massachusetts General Hospital|Amgen | Osteoporosis | 2009-06 | PHASE2 |
| NCT01824342 | Amgen | Castrate-resistant Prostate Cancer | 2011-01 | PHASE3 |
| NCT04206618 | 424 General Military Hospital|Beth Israel Deaconess Medical Center | Osteoporosis, Postmenopausal | 2019-06-01 | |
| NCT05662358 | Shenzhen People´s Hospital | Denosumab Allergy | 2021-01-03 | NA |
| NCT01558115 | Columbia University|National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Amgen | Primary Hyperparathyroidism | 2012-01 | PHASE4 |
| NCT07056478 | Prince of Wales Hospital, Shatin, Hong Kong | Sarcopenia in Elderly | 2026-01-01 | PHASE3 |
| NCT02632916 | Children´s Hospital of Eastern Ontario | Osteoporosis | 2016-08 | PHASE2 |
| NCT03792763 | Arbeitsgemeinschaft medikamentoese Tumortherapie|Amgen|Assign Data Management and Biostatistics GmbH | Multiple Myeloma | 2019-09-30 | PHASE2 |
| NCT04241211 | Seoul National University Bundang Hospital | Spine Deformity | 2014-01-01 | PHASE4 |
| NCT01495000 | GlaxoSmithKline | Osteoporosis, Postmenopausal | 2012-01 | PHASE3 |
| NCT01465568 | Tuen Mun Hospital | Osteoporosis | 2011-12 | PHASE4 |
| NCT04067726 | Washington University School of Medicine|National Institutes of Health (NIH) | Dense Breasts | 2019-08-27 | PHASE2 |
| NCT06374459 | Washington University School of Medicine|United States Department of Defense|Aclaris Therapeutics, Inc. | Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer | 2025-01-30 | PHASE1|PHASE2 |
| NCT01294397 | Amgen | Postmenopausal|Osteopenia|Rheumatoid Arthritis|Osteoporosis | 2011-03 | PHASE1 |
| NCT02833610 | Massachusetts General Hospital|Amgen|Emory University|University of Rochester|University Hospitals Cleveland Medical Center | Multiple Myeloma | 2016-08 | PHASE2 |
| NCT02135640 | GlaxoSmithKline | Osteoporosis | 2014-07-17 | PHASE1 |
| NCT00089791 | Amgen | Osteoporosis | 2004-08-01 | PHASE3 |
| NCT01575873 | Amgen | Steroid-induced Osteopor, Glucocorticoid-induced Ostepor | 2012-03-28 | PHASE3 |
| NCT01358669 | Sheffield Teaching Hospitals NHS Foundation Trust|Amgen|University of Sheffield | Revision Surgery of Total Hip Arthroplasty | 2011-12-14 | PHASE2 |
| NCT01464931 | Amgen | Renal Impairment | 2011-11 | PHASE1 |
| NCT03161756 | Melanoma and Skin Cancer Trials Limited|Peter MacCallum Cancer Centre, Australia|Amgen|Bristol-Myers Squibb | Melanoma Stage Iv|Melanoma Stage Iii|Melanoma | 2017-12-07 | PHASE1|PHASE2 |
| NCT03732495 | Centre Leon Berard | Thyroid Cancer Metastatic | 2019-07-26 | PHASE2 |
| NCT04085419 | University Medical Centre Ljubljana | Primary Hyperparathyroidism|Osteoporosis | 2019-05-08 | PHASE4 |
| NCT02352753 | Amgen | Osteogenesis Imperfecta | 2015-06-24 | PHASE3 |
| NCT00890981 | Amgen | Low Bone Mass|Low Bone Mineral Density|Osteoporosis|Postmenopausal Osteoporosis | 2009-07 | PHASE3 |
| NCT02792413 | University Hospital, Montpellier | Female With Osteoporosis and Chronic Kidney Disease | 2018-11-19 | PHASE4 |
| NCT06513624 | National University Hospital, Singapore|EDDC (Experimental Drug Development Centre), A*STAR Research Entities | With MSS+pMMR Advanced, Platinum-resistant Ovarian Cancer | 2024-12-09 | PHASE1 |
| NCT02132026 | University of Edinburgh|British Heart Foundation|NHS Lothian | Calcific Aortic Stenosis | 2014-11-12 | PHASE2 |
| NCT01770106 | Chinese University of Hong Kong | Rheumatoid Arthritis | 2012-12 | PHASE4 |
| NCT03839459 | University of Rochester|Amgen | Smoldering Multiple Myeloma | 2019-04-19 | PHASE2 |
| NCT02435147 | HealthEast Care System|Amgen | Osteoporosis|Bone Fracture | 2015-04 | |
| NCT05212337 | Martin Blomberg Jensen | Infertility, Male | 2022-01-01 | PHASE2 |
| NCT03691311 | Institut Català d´Oncologia|Amgen | Breast Neoplasm Female|Stage I Breast Cancer|Stage II Breast Cancer|Hormone Receptor Negative Neoplasm|Hormone Receptor Positive Tumor | 2018-07-05 | EARLY_PHASE1 |
| NCT02900469 | NYU Langone Health | Breast Cancer | 2016-10 | EARLY_PHASE1 |